Abbott Laboratories

Abbott Laboratories Beats on EPS, Stock Down 0.29%

Abbott Laboratories reported an EPS of $0.54, which exceeded expectations by 6.51%. However, the stock reacted negatively, declining by 0.29%. The lack of revenue data and management commentary may have contributed to investor uncertainty.